Intradermal Delivery of Cell Vaccine via Ice Microneedles for Cancer Treatment
Advanced Healthcare Materials · 2025-01 · 14 (1)
DOI: 10.1002/adhm.202400678 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.11.2024. Verfasst von Chunli Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, #17 Section 3, Renmin South …. Hauptthemen laut MEDLINE: Cancer Vaccines, Needles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Sichuan University Postdoctoral Interdisciplinary Innovation Fund.
Abstract (Originalsprache)
The living tumor cell vaccine (TCV) holds a promise for cancer immunotherapy. Microneedle arrays provide a tool to improve the immune response of vaccines by the intradermal administration in a painless manner. However, it remains challenges for microneedle arrays to deliver the living TCV intradermally. Here, an ice microneedle array delivered living TCVs is shown with sustained granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) secretion for cancer treatment. The ice microneedle array is composed of ice microneedles and a matching polymer holder, which are customized fabricated by a static optical projection lithography (SOPL) technique. The living TCV consisted of irradiated melanoma cells transfected with nanoparticle‐mediated GM‐CSF plasmids. After the living TCV is readily loaded into the ice microneedle via a cryopreservation process, it could be efficiently delivered into the dermis by the microneedle device. Compared to the subcutaneous injection, intradermal administration led to the recruitment of more dendritic cells at the vaccination site and the increased infiltration of CD8 + T cells in the tumor. The ice microneedle array deliveres intradermal TCVs significantly inhibited melanoma growth and effectively prevented melanoma recurrence without obvious side effects. This work demonstrates a promising TCVs for melanoma treatment, which will inspire the future of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, #17 Section 3, Renmin South Road, Chengdu, Sichuan Province, 610041, China.
- Department of Oncology, West China Hospital, Sichuan University, #37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, 610041, China.
- Huahang Microcreate Technology Co., Ltd, #818 Shixing Road, Wuhou District, Chengdu, Sichuan Province, 610041, China.
- Department of Chemistry, University of Washington-Seattle Campus, 1410 NE Campus Pkwy, Seattle, WA, 98195, USA.
- Department of Plastic and Burn Surgery, West China Hospital, Sichuan University, #37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, 610041, China.
ORCID-Profile: Maling Gou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- Sichuan University Postdoctoral Interdisciplinary Innovation Fund
- 1·3·5 Project for Disciplines of Excellence, West China Hospital, Sichuan University
Zitieren
APA
Yang, C., Zhao, W., Zhang, L., He, L., Wang, S., Wang, J., Xiang, M., Yuan, X., & Gou, M. (2025). Intradermal Delivery of Cell Vaccine via Ice Microneedles for Cancer Treatment. Advanced Healthcare Materials, 14(1). https://doi.org/10.1002/adhm.202400678
Vancouver
Yang C, Zhao W, Zhang L, He L, Wang S, Wang J, et al. Intradermal Delivery of Cell Vaccine via Ice Microneedles for Cancer Treatment. Advanced Healthcare Materials. 2025;14(1). doi:10.1002/adhm.202400678
BibTeX
@article{Yang2025,
author = {Yang, Chunli and Zhao, Wei and Zhang, Li and He, Liming and Wang, Siyi and Wang, Jie and Xiang, Maya and Yuan, Xin and Gou, Maling},
title = {Intradermal Delivery of Cell Vaccine via Ice Microneedles for Cancer Treatment},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {1},
doi = {10.1002/adhm.202400678}
}
EUVIMED